Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06352073
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2024-04-01
Brief Title:
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Organization Data
Organization:
University of North Carolina Chapel Hill
Class:
OTHER
Study ID:
23-2625
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of North Carolina Chapel Hill
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |
| Regeneron Pharmaceuticals | INDUSTRY |